Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-22

Clinical Trial Update: Feasibility of an Online Cognitive Behavioural Therapy Application (Mahana IBS™, Mahana Therapeutics) in the Management of Irritable Bowel Syndrome [NA]

View source ↗

Summary

A clinical trial evaluating the feasibility of an online cognitive behavioral therapy application (Mahana IBS) for irritable bowel syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mahana IBS

Snippet

Sponsor: Nottingham University Hospitals NHS Trust | Conditions: Irritable Bowel Syndrome (IBS) | NA | Status: TERMINATED